All filters
Videos
Rationale for modulating innate immunity: TLR, RIG- and others | Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2018
Videos
Antiviral effect of the RIG-I agonist, Inarigavir | Nezam Afdahl
Presented at:
International Workshop on HBV Cure 2018
Videos
Session 3 Panel discussion
Presented at:
International Workshop on HBV Cure 2018
Videos
Rationale for Modulating Adaptive Immunity | Robert Thimme
Presented at:
International Workshop on HBV Cure 2018
Videos
What is the cure rate with current therapies? | Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2018
Videos
Clinical update on reducing HBV virus and antigen production using RNAi | Bruce Given
Presented at:
International Workshop on HBV Cure 2018
Videos
Session 4 Panel discussion
Presented at:
International Workshop on HBV Cure 2018
Videos
Targeting HBV Core Protein to Clear Infection and Achieve Higher Cure Rates | Richard Colonno
Presented at:
International Workshop on HBV Cure 2018
Videos
Clinical progress of the entry inhibitor Myrcludex B | Stephan Urban
Presented at:
International Workshop on HBV Cure 2018